SCPS:OTC-Scopus Biopharma Inc (USD)

COMMON STOCK | Biotechnology |

Last Closing

USD 0.0001

Change

0.00 (0.00)%

Market Cap

USD 4.21K

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-05 )

Largest Industry Peers for Biotechnology

Symbol Name Price(Change) Market Cap
UCBJY UCB SA ADR

+0.63 (+0.69%)

USD 34.60B
UCBJF UCB SA

N/A

USD 34.60B
ARGNF argenx SE

N/A

USD 31.72B
GNMSF Genmab A/S

-1.52 (-0.64%)

USD 15.44B
IVBIY IVBIY

N/A

USD 9.33B
ZLDPF Zealand Pharma A/S

N/A

USD 8.69B
SBHMY Sino Biopharmaceutical Ltd ADR

N/A

USD 8.66B
SBMFF Sino Biopharmaceutical Limited

N/A

USD 8.66B
WXIBF WuXi Biologics

N/A

USD 8.63B
WXXWY WuXi Biologics (Cayman) Inc

N/A

USD 8.44B

ETFs Containing SCPS

IEO 19.09 % 0.42 %

N/A

N/A
IS0D:F iShares Oil & Gas Explora.. 10.25 % 0.00 %

N/A

N/A
IS0D:XETRA iShares Oil & Gas Explora.. 10.25 % 0.00 %

+0.56 (+2.40%)

USD 0.32B
NRGD 10.00 % 0.00 %

N/A

N/A
NRGU 10.00 % 0.00 %

N/A

N/A
NRGO 10.00 % 0.00 %

N/A

N/A
NRGZ 10.00 % 0.00 %

N/A

N/A
YGRN 10.00 % 0.00 %

N/A

N/A
IOGP:LSE iShares Oil & Gas Explora.. 9.71 % 0.00 %

+0.48 (+2.40%)

N/A
SPOG:LSE iShares V Public Limited .. 9.71 % 0.00 %

+42.75 (+2.40%)

N/A
FRAK 8.73 % 0.54 %

N/A

N/A
SXLE:LSE SPDR S&P U.S. Energy Sele.. 8.57 % 0.00 %

+0.53 (+2.40%)

N/A
FTXN First Trust Nasdaq Oil & .. 7.71 % 0.60 %

+0.32 (+2.40%)

USD 0.17B
IESU:LSE iShares S&P 500 Energy Se.. 7.69 % 0.00 %

+10.88 (+2.40%)

N/A
IUSE:LSE iShares S&P 500 EUR Hedge.. 7.69 % 0.00 %

+0.09 (+2.40%)

USD 6.09B
QDVF:F iShares S&P 500 Energy Se.. 7.69 % 0.00 %

+0.17 (+2.40%)

N/A
QDVF:XETRA iShares S&P 500 Energy Se.. 7.69 % 0.00 %

+0.17 (+2.40%)

USD 0.98B
XUEN:F Xtrackers (IE) Public Lim.. 7.53 % 0.00 %

+1.89 (+2.40%)

USD 0.09B
XUEN:XETRA db x-trackers MSCI USA En.. 7.53 % 0.00 %

+0.89 (+2.40%)

USD 0.09B
IYE iShares U.S. Energy ETF 7.32 % 0.42 %

+0.47 (+2.40%)

N/A
XSEN:LSE db x-trackers MSCI USA En.. 7.12 % 0.00 %

+57.75 (+2.40%)

USD 0.07B
XUEN:LSE db x-trackers MSCI USA En.. 7.12 % 0.00 %

+0.69 (+2.40%)

USD 0.07B
JHME 6.90 % 0.48 %

N/A

N/A
NXF-B:CA CI Energy Giants Covered .. 6.66 % 0.00 %

+0.06 (+2.40%)

CAD 0.02B
FENY Fidelity® MSCI Energy In.. 6.44 % 0.08 %

+0.24 (+2.40%)

USD 1.53B
DIG ProShares Ultra Oil & Gas 5.89 % 0.95 %

+0.70 (+2.40%)

N/A
DDG 5.83 % 0.95 %

N/A

N/A
DUG ProShares UltraShort Oil .. 5.83 % 0.95 %

-0.17 (2.40%)

N/A
ERX Direxion Daily Energy Bul.. 5.21 % 1.08 %

+1.20 (+2.40%)

N/A
HPF:CA Energy Leaders Plus Incom.. 4.96 % 1.74 %

+0.03 (+2.40%)

N/A
HPF-U:CA Harvest Energy Leaders Pl.. 4.96 % 0.00 %

+0.08 (+2.40%)

N/A
ERYY 4.79 % 0.45 %

N/A

N/A
XDW0:LSE db x-trackers MSCI World .. 4.70 % 0.00 %

+0.77 (+2.40%)

N/A
XDW0:F Xtrackers (IE) Public Lim.. 4.70 % 0.00 %

+1.01 (+2.40%)

USD 1.07B
XDW0:XETRA db x-trackers MSCI World .. 4.70 % 0.00 %

+0.89 (+2.40%)

USD 1.07B
FILL iShares MSCI Global Energ.. 4.63 % 0.39 %

+0.27 (+2.40%)

USD 0.09B
5MVW:XETRA iShares MSCI World Energy.. 4.53 % 0.00 %

+0.16 (+2.40%)

USD 0.59B
IGE 4.50 % 0.46 %

N/A

N/A
IXC iShares Global Energy ETF 4.50 % 0.46 %

+0.45 (+2.40%)

N/A
WNRG:LSE SPDR MSCI World Energy UC.. 4.47 % 0.00 %

+0.73 (+2.40%)

N/A
HUL-U:CA 4.46 % 0.00 %

N/A

N/A
HUL:CA 4.46 % 2.20 %

N/A

N/A
ZPDE:F SPDR S&P U.S. Energy Sele.. 4.46 % 0.00 %

+0.60 (+2.40%)

USD 0.78B
ZPDE:XETRA SPDR® S&P® U.S. Energy .. 4.46 % 0.00 %

+0.63 (+2.40%)

USD 0.78B
FCG First Trust Natural Gas E.. 4.33 % 0.60 %

+0.21 (+2.40%)

N/A
GASX 4.29 % 1.01 %

N/A

N/A
NANR SPDR S&P® North American.. 4.17 % 0.35 %

+0.36 (+2.40%)

N/A
EQRR ProShares Equities for Ri.. 2.90 % 0.35 %

+0.85 (+2.40%)

USD 0.01B
HEA:CA 2.61 % 0.00 %

N/A

N/A
HEA-U:CA 2.61 % 0.00 %

N/A

N/A
FCUQ:CA Fidelity U.S. High Qualit.. 2.19 % 0.00 %

+0.43 (+2.40%)

CAD 0.61B
SPGP Invesco S&P 500 GARP ETF 1.97 % 0.36 %

+1.28 (+2.40%)

USD 4.24B
GASL 1.45 % 1.19 %

N/A

N/A
TERM 0.88 % 0.64 %

N/A

N/A
RIRA:CA Russell Investments Real .. 0.61 % 0.00 %

-0.06 (2.40%)

CAD 0.21B
SCHJ Schwab 1-5 Year Corporate.. 0.09 % 0.00 %

-0.19 (2.40%)

N/A
BWX SPDR® Bloomberg Internat.. 0.00 % 0.50 %

-0.18 (2.40%)

N/A
EBND SPDR® Bloomberg Emerging.. 0.00 % 0.41 %

-0.16 (2.40%)

N/A
ILF iShares Latin America 40 .. 0.00 % 0.48 %

+0.27 (+2.40%)

N/A
MTUM 0.00 % 0.15 %

N/A

N/A
RYE 0.00 % 0.40 %

N/A

N/A
WIP SPDR® FTSE International.. 0.00 % 0.50 %

-0.50 (2.40%)

N/A
SMRU:LSE Amundi Index Solutions - .. 0.00 % 0.00 %

+1.71 (+2.40%)

N/A
SM8T:F Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Biotechnology) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -99.77% 2% F N/A F
Dividend Return N/A N/A N/A N/A N/A
Total Return -99.77% 2% F N/A F
Trailing 12 Months  
Capital Gain -99.87% 2% F 1% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -99.87% 2% F 1% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -64.45% 1% F N/A F
Dividend Return -64.45% 1% F N/A F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 40.90% 72% C 57% F
Risk Adjusted Return -157.58% 2% F N/A F
Market Capitalization 4.21K 8% B- 5% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.